SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-009125
Filing Date
2020-03-20
Accepted
2020-03-20 16:31:28
Documents
1
Period of Report
2020-03-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4248
  Complete submission text file 0000899243-20-009125.txt   5712
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Issuer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19900 MACARTHUR BLVD., SUITE 550 IRVINE CA 92612
Business Address
TURKEL CATHERINE C. (Reporting) CIK: 0001705278 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36620 | Film No.: 20732350